The objective of this study was to investigate whether the apoptosis and chemosensitivity of HDAC inhibitors-resistant hepatocellular carcinoma cells could be regulated by fisetin, and to determine which molecular mechanisms and signaling pathways were involved. The gene discussed is HDAC9; the disease is hepatocellular carcinoma.